388 results on '"Eckelman, W"'
Search Results
2. Vascular-Targeted Radioimmunotherapy with the Alpha-Particle Emitter ${}^{211}{\rm At}$
3. Principles of molecular targeting for radionuclide therapy
4. Schizophrenia is Associated with Elevated Amphetamine-Induced Synaptic Dopamine Concentrations: Evidence from a Novel Positron Emission Tomography Method
5. Trend Analysis of Quality Control Data
6. Future Development of Radiopharmaceuticals
7. Molecular Imaging and Contrast Agent Database (MICAD): Evolution and Progress
8. Genetic variation in cholinergic muscarinic-2 receptor gene modulates M2 receptor binding in vivo and accounts for reduced binding in bipolar disorder
9. Why does the agonist [18F]FP-TZTP bind preferentially to the M2 muscarinic receptor?
10. Regional brain uptake of the muscarinic ligand, [18F]FP-TZTP, is greatly decreased in M2 receptor knockout mice but not in M1, M3 and M4 receptor knockout mice
11. VIP and Breast Cancer
12. A Muscarinic Receptor Ligand: Review of the Chemistry and Applications
13. Kinetic Analysis of 3-Quinuclidinyl 4-[125I]Iodobenzilate Transport and Specific Binding to Muscarinic Acetylcholine Receptor in Rat Brain in vivo: Implications for Human Studies
14. NMR Enhancement with Gd Labeled Antibodies
15. Exchange labeling of proteins:99mTc labeled transferrin
16. Synthesis, plasma clearance, and in vitro stability of protein containing a conjugated indium-111 chelate
17. [Br-76]BMK-I-152, a non-peptide analogue for PET imaging of corticotropin-releasing hormone type 1 receptor (CRHR1)
18. Postmeeting summary on the round table discussion at the Seventh International Symposium on Technetium in Chemistry and Nuclear Medicine held in Bressanone, Italy on Sept 6-9, 2006
19. Molecular Imaging and Contrast Agent Database (MICAD): Evolution and Progress
20. Genetic variation in cholinergic muscarinic-2 receptor gene modulates M2 receptor binding in vivo and accounts for reduced binding in bipolar disorder
21. [76Br]BMK-I-152, a non-peptide analogue for PET imaging of corticotropin-releasing hormone type 1 receptor (CRHR1)
22. A Series of Halogenated Heterodimeric Inhibitors of Prostate Specific Membrane Antigen (PSMA) as Radiolabeled Probes for Targeting Prostate Cancer
23. Synthesis and validation of fatty acid analogs radiolabeled by nonisotopic substitution
24. Early imaging in heart failure: Exploring novel molecular targets
25. Imaging of Muscarinic Receptors in the Central Nervous System
26. TH‐E‐330D‐01: BIROW ‐ Biomedical Imaging Research Opportunities Workshop: Intersociety Project to Accelerate Biomedical Imaging Discovery and Application ‐ Part II
27. TH‐D‐330D‐01: BIROW — Biomedical Imaging Research Opportunities Workshop: Intersociety Project to Accelerate Biomedical Imaging Discovery and Application
28. National cancer institute workshop statement. Advances in clinical imaging using positron emission tomography, September 14-16, 1988
29. Why does the agonist [18F]FP-TZTP bind preferentially to the M2 muscarinic receptor?
30. Semi-remote production of [64Cu]CuCl2 and preparation of high specific activity [64Cu]Cu-ATSM for PET studies
31. Semi-remote production of Br-76 and preparation of high specific activity radiobrominated pharmaceuticals for PET studies
32. In Memoriam Gerhard L. Stöcklin
33. Production and radioassay of Tc-94m for PET studies
34. The use of PET and knockout mice in the drug discovery process
35. Nonpeptide corticotropin releasing hormone type 1 receptor antagonists as medications and imaging agents
36. The development of additional radioligands of varying pharmacokinetics for the 5-HT1A receptor
37. Synthesis of [76Br] 1-(2-fluoro-2-deoxy-3,5-O-dibenzoyl-β-D-arabinofuranosyl)-5-BRO mouracil([76Br]FBAU 3′,5′-dibenzoate) and its evaluation as a tracer for imaging brain cell proliferation
38. Production and radioassay of TC-94M for pet studies
39. Radiolabeling of unprotected octreotide with F-18
40. Cyclotron production and potential clinical application of Iodine-124 labeled radiotracers.
41. Measurement of transferrin receptor kinetics in the baboon liver using dynamic positron emission tomography imaging and [18F]holo-transferrin
42. Kinetic analysis of muscarinic receptors in human brain and salivary gland in vivo
43. In vivo estimates of synaptic dopamine concentrations with 11C-raclopride/pet: A direct test of the dopamine hypothesis
44. Synthesis, characterization, and in vitro evaluation of nitroimidazole-BATO complexes: New technetium compounds designed for imaging hypoxic tissue
45. True tracer radiolabeling of gadolinium complex of 10-(2-hydroxypropyl)-1,4,7,10-tetraazacyclododecane-1,4,7 triacetic acid (HP-DO3A)
46. Genetic variation in cholinergic muscarinic-2 receptor gene modulates M2 receptor binding in vivo and accounts for reduced binding in bipolar disorder.
47. Technetium-labeling of monoclonal antibodies with functionalized BATOs: 2. TcCl(DMG)3CPITC (CPITC=carboxyphenylisothiocyanate) labeling of B72.3 and NP-4 whole antibodies and NP-4 F(ab')2
48. [76Br]BMK-I-152, a non-peptide analogue for PET imaging of corticotropin-releasing hormone type 1 receptor (CRHR1).
49. Technetium labeling of monoclonal antibodies with functionalized BATOs. 1. TcCl(DMG)3PITC [phenyl isothiocyanate].
50. Why does the agonist [18F]FP-TZTP bind preferentially to the M2 muscarinic receptor?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.